

Novartis UK is pleased to invite you to the upcoming webinar...
Severe Asthma Masterclass:
Optimising severe asthma care in 2021
22nd March 2021
19:00 - 20:45
This promotional meeting is organised and funded by Novartis Pharmaceuticals UK Limited.
UK | February 2021 | 105572
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.UK/yellowcard (UK).
Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about a product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com
To learn about your data privacy rights and the use of your personal information, we invite you to read our General Privacy Notice for Business Partners.